InSilico Medicine
Latest round
- Series E
Last raised
- Mar 2025
Total raised
- $497M
Investors
- 31
About InSilico Medicine
, dba InSilico Medicine, operates an artificial intelligence platform for drug development to treat cancer and age-related diseases. The company was founded by its CEO, Alex Zhavoronkov. The company has its R&D operations in the USA, Belgium, Russia, UK, Taiwan, and China. The company’s Chairman, Executive Director and CEO, Alex Zhavoronkov, published over 150 peer-reviewed research papers and 2 books, including “The Ageless Generation: How Biomedical Advances Will Transform the Global Economy” (Macmillan, 2013).05 per share on the Hong Kong Exchanges and Clearing Limited, under ticker "03696". InSilico Medicine provides drug discovery engines used in the drug development process, digital medicine, and finding novel solutions for age-related and severe diseases using genomics and big data analysis. The company also provides drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson’s diseases, and Alzheimer’s diseases. InSilico Medicine's products include PandaOmics, a multinomial target discovery, a deep biology engine that enables disease target identification, Chemistry42, the generation of synthetic biology and novel molecules' data, and InClinico for predicting trial outcomes.AI platform and by developing and potentially licensing its own preclinical product pipelines.
Who invested in InSilico Medicine
31 investors across 9 rounds
See all investors in InSilico Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Mar 13, 2025
Amount
$110M
Investors
Series D
Aug 10, 2022
Amount
$35M
Investors
Series D
Jun 6, 2022
Amount
$60M
Investors
Series C
Jun 22, 2021
Amount
$255M
Investors
Series B
Apr 20, 2020
Amount
Undisclosed
Investors
Series B
Sep 9, 2019
Amount
$37M
Investors
Series B
Aug 12, 2019
Amount
Undisclosed
Investors
Seed
Nov 1, 2015
Amount
Undisclosed
Investors
Seed
Apr 16, 2014
Amount
Undisclosed
Investors
Questions about InSilico Medicine
Who invested in InSilico Medicine?
InSilico Medicine has 31 investors on record across 9 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InSilico Medicine raised?
InSilico Medicine has raised 9 venture rounds. Sign up free to see how much each round raised and the total.
When did InSilico Medicine last raise money?
InSilico Medicine's most recent round on record is a Series E, in Mar 2025.
What does InSilico Medicine do?
, dba InSilico Medicine, operates an artificial intelligence platform for drug development to treat cancer and age-related diseases.
Where is InSilico Medicine headquartered?
InSilico Medicine is headquartered in Hong Kong, Hong Kong SAR - China.
Which VCs invest in companies like InSilico Medicine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at InSilico Medicine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like InSilico Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.